2-hydroxy docosahexaenoic acid (Laminar Pharmaceuticals)

N/A

Report date: 2024/03/01 15:09:34
NME

Base Information

Drug Name2-hydroxy docosahexaenoic acid (Laminar Pharmaceuticals)
Drug Alias NameLP-226A1DHA-HLAM-226
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMembrane lipids modulatorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsNeurodegenerative DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLaminar Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Active CompaniesLaminar Pharmaceuticals SA
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A